Mode
Text Size
Log in / Sign up
N/A Completed N=731 Randomized Triple-blind Treatment

Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety

Neuromuscular Blockade · Rocuronium · Anesthetics · Anesthesia Complication
Source: ClinicalTrials.gov NCT04124757 ↗
Enrolled (actual)
731
Serious AEs
6.5%
Results posted
Jun 2025
Primary outcomePrimary: Classic Score>1 — 66; 54 participants

Summary

Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) improves the surgical working conditions over a moderate NMB and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. Small prospective or retrospective studies shown an decrease of the incidence of intraoperative adverse events and postoperative complications after a deep NMB. There is a need to confirm these outcome data prospectively, in a large number of patients and clinics and during a variety of surgical procedures.

Outcome Measures

OutcomeResultp-value
PRIMARY
Classic Score>1
66; 54
SECONDARY
L-SRS (Leiden Surgical Rating Scale)
4.6; 4.9
SECONDARY
30 Day Post-operative Complications
142; 139
SECONDARY
Quality of Recovery (QoR)
SECONDARY
Quality of Life (QoL)

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'
  • ASA (merican society of anesthesiologists) class I-III
  • > 18 years of age
  • Ability to give oral and written informed consent

Exclusion Criteria

  • Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')
  • Known or suspected neuromuscular disorders impairing neuromuscular function
  • Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2
  • A (family) history of malignant hyperthermia
  • Women who are or may be pregnant or are currently breast feeding
  • Chronic use of any type of opioid or psychotropic drug
  • Use of NSAID's shorter than 5 days before surgery
  • Indication for rapid sequence induction
  • Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular Filtration Rate <30 ml/min)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04124757). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search